Coughlin Stoia Geller Rudman & Robbins LLP
Files Class Action Suit against St. Jude Medical,
Inc.
March 18, 2010 05:56 PM Eastern Daylight Time
NEW YORK--(EON: Enhanced Online News)--Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”)
(http://www.csgrr.com/cases/stjudemedical/) today announced that a class action has been commenced on behalf of
an institutional investor in the United States District Court for the District of Minnesota on behalf of purchasers of the
common stock of St. Jude Medical, Inc. (“St. Jude” or the “Company”) (NYSE:STJ) between April 22, 2009 and
October 6, 2009, inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of
1934 (the “Exchange Act”).
If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to
discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s
counsel, Samuel H. Rudman or David A. Rosenfeld of Coughlin Stoia at 800/449-4900 or 619/231-1058, or via e-
mail at djr@csgrr.com. If you are a member of this Class, you can view a copy of the complaint as filed or join this
class action online at http://www.csgrr.com/cases/stjudemedical/. Any member of the putative class may move the
Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent
class member.
The complaint charges St. Jude and certain of its officers and executives with violations of the Exchange Act. St.
Jude develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices
worldwide.
The complaint alleges that, throughout the Class Period, defendants failed to disclose material adverse facts about
the Company’s true financial condition, business and prospects. Specifically, the complaint alleges that defendants
failed to disclose: (i) that the Company was experiencing a slowdown in demand for its products as hospitals
reduced pur